{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/pruritus-vulvae/","result":{"data":{"firstChapter":{"id":"e95d24eb-aeb8-50bb-ac51-8f64aea3c30a","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 0e4173d4-8317-4440-8c8c-ed27c854a243 --><h1>Pruritus vulvae: Summary</h1><!-- end field 0e4173d4-8317-4440-8c8c-ed27c854a243 -->","htmlStringContent":"<!-- begin item 9fa91b15-f9bf-4819-a630-50c3aafe0d4a --><!-- begin field 64b88e31-b328-43e4-946d-a22fb3db2579 --><ul><li>Pruritus vulvae is itching of the vulva (which includes the mons pubis, labia majora, labia minora, clitoris, perineum and the external openings of the urethra and vagina). It is a symptom which is common to many conditions.</li><li>An underlying cause can usually be identified from the history and examination. These include:<ul><li>Dermatological conditions.</li><li>Infections and infestations.</li><li>Neoplastic conditions.</li><li>Hormonal changes (atrophic vaginitis).</li><li>Gastrointestinal disease and urinary incontinence.</li><li>Systemic causes.</li></ul></li><li>Complications may result from the underlying causes: <ul><li>There is a small risk of developing squamous cell carcinoma for women with lichen sclerosus (less than 5%), and lichen planus (less than 3%).</li></ul></li><li>Complications may also result from chronic itch:<ul><li>Psychological problems, such as depression, and anxiety.</li><li>Sleep disturbance.</li><li>Severe and irreversible architectural damage due to chronic, deep scratching and gouging.</li><li>Lichen simplex. </li></ul></li><li>Secondary bacterial infection (usually with <em>Staphylococcus aureus</em>) is common in excoriated skin.</li><li>It should be confirmed that the woman is experiencing vulval itch, not vulval pain.</li><li>A careful history should be taken and include questions about:<ul><li>Location, duration and onset of symptoms.</li><li>Trigger factors.</li><li>Associated symptoms.</li><li>Hygiene practices and products.</li><li>Use of prescribed and over the counter medicines. </li><li>Contraception used.</li><li>Other medical conditions, or a personal or family history of atopic conditions.</li></ul></li><li>Assessment should determine the severity of symptoms and the impact this is having on the woman.</li><li>Examination of the anogenital region should be carried out, in addition to an examination of extragenital sites. </li><li>The woman should be advised to shower rather than bath, and to clean the vulval area only once a day with a soap substitute.  <ul><li>Once the vulval area is clean, it should be gently dabbed dry with a soft towel or dried with a hairdryer on a cool setting held well away from the skin.</li></ul></li><li>Women with pruritus vulvae should be advised to avoid:<ul><li>Washing with water only or with soap as these cause dry skin and make itching worse.</li><li>Contact of the vulval skin with shampoo, bubble bath, vaginal washes, or wet wipes.</li><li>Tight-fitting garments or synthetic clothes.</li><li>Fabric conditioner or biological washing powder.</li><li>Spermicidally-lubricated condoms.</li><li>Coloured toilet paper.</li></ul></li><li>Underlying causes of pruritus vulvae should be managed appropriately.</li><li>The aim of treatment is to provide symptomatic relief, reduce inflammation, restore the skin barrier and prevent and/or treat secondary infection. This involves:<ul><li>Offering symptomatic treatment with an emollient and a mildly anxiolytic<strong> </strong>antihistamine.</li><li>Considering a short trial (1-2 weeks) of low potency topical corticosteroids (hydrocortisone 1% ointment).</li><li>Considering prescribing a combination corticosteroid/antifungal, or corticosteroid/antibacterial if a co-existing infection is suspected.</li></ul></li><li>Referral to a dermatologist or gynaecologist is indicated if the cause is unclear and symptoms persist.<ul><li>Urgent referral (within 2 weeks) is indicated if vulval carcinoma is suspected (for example, an unexplained vulval lump or ulcer).</li></ul></li></ul><!-- end field 64b88e31-b328-43e4-946d-a22fb3db2579 --><!-- end item 9fa91b15-f9bf-4819-a630-50c3aafe0d4a -->","topic":{"id":"ab775596-ee36-566c-b99e-f26281476587","topicId":"f736b71a-0394-4d1b-81d3-89f92387f7b5","topicName":"Pruritus vulvae","slug":"pruritus-vulvae","aliases":[],"chapters":[{"id":"e95d24eb-aeb8-50bb-ac51-8f64aea3c30a","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"8ce4dbd7-2246-5775-ae6e-04329c1190c1","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"982a2f05-e887-58b7-b162-572ce0d3ee9f","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"38dfa294-fe36-5eaf-801f-f85edcaf9b0c","slug":"changes","fullItemName":"Changes"},{"id":"3ad7e907-7bc6-5339-9fe3-a53a943a1d5b","slug":"update","fullItemName":"Update"}]},{"id":"cfeab3a1-33f8-5401-bf2d-554006509e44","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"f358fbd3-3112-597d-8318-782024ffb462","slug":"goals","fullItemName":"Goals"},{"id":"06d9f87d-ffb9-5c80-94cc-c14fabec72e4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"00abbaa1-76de-5699-92e4-c7966d120fb9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8c5bcf9e-40a1-5ec5-bfb3-8b61c5e05271","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"9e5947c9-06ae-527b-b39d-99249cc183b7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"acce3106-835f-51e5-8d2a-474eb1210f06","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ede3d467-474d-5337-a3a8-69e962cdb78d","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"fed1d461-c450-5ad2-b137-ba2e7b3e25ba","slug":"definition","fullItemName":"Definition"},{"id":"69ac7b79-9272-52fb-b41a-85c62d368278","slug":"causes","fullItemName":"Causes"},{"id":"540240f7-7b5f-5dd8-9778-add2bad7a948","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f32fb44d-4398-544d-8e12-40abce15c8ac","slug":"prognosis","fullItemName":"Prognosis"},{"id":"d3481fe5-fb32-5604-a01e-ef3831740641","slug":"complications","fullItemName":"Complications"}]},{"id":"ea7b6574-3e2d-5558-b3fc-e26e23ee9841","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"cb8a05d1-5735-53f1-9f3d-a8eeeaf04c43","slug":"assessment","fullItemName":"Assessment"},{"id":"d9fb23e4-f170-5e35-baf1-eb5e9eb3ef93","slug":"causes","fullItemName":"Causes"},{"id":"b2f116aa-c92b-555e-bf3d-4d48002ac082","slug":"investigations","fullItemName":"Investigations"}]},{"id":"33ec4dfa-a698-5c63-ba2b-63ff2bd4f94a","slug":"management","fullItemName":"Management","subChapters":[{"id":"39b5f2b6-2faf-5764-932b-10c3cfa35b9c","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"879b4dcf-9fd5-5785-ad0a-f78ce4711c69","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"40a71a96-802a-52ed-936a-8be2564e3966","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids"},{"id":"5a7e3fc5-3dcc-5ae7-b42c-cfd50c0b6427","slug":"hydroxyzine","fullItemName":"Hydroxyzine"}]},{"id":"e8fd8512-18b4-5a87-b393-c17a7aeea18c","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"22929cbe-97bb-51fd-848d-fb564e84e824","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"16e021f3-7a43-5db6-91c6-f2928df8f0d3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"1e67be49-3ad9-5c49-afd7-3b4003a9e1ac","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"aa214653-3cef-5171-bc52-2abc1dca4efe","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9f82fff6-ebda-5cfb-8995-424680c23073","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3a44b88d-e6de-5027-a2a5-aab8d22fae10","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2255e17a-9ac2-5004-9c32-22c36192790a","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"ab775596-ee36-566c-b99e-f26281476587","topicId":"f736b71a-0394-4d1b-81d3-89f92387f7b5","topicName":"Pruritus vulvae","slug":"pruritus-vulvae","aliases":[],"topicSummary":"Pruritus vulvae is itching of the vulva (which includes the mons pubis, labia majora, labia minora, clitoris, perineum, urethra and vagina","lastRevised":"Last revised in May 2017","nextPlannedReviewBy":"2022-05-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-04","nextPlannedReviewByDisplay":"April 2022","specialities":[{"id":"f05d0400-7348-5229-ab3e-400d91618189","name":"Sexual health","slug":"sexual-health"},{"id":"50071c38-ab10-5ab8-ac70-6bd19a96c24e","name":"Skin and nail","slug":"skin-nail"},{"id":"0c813417-9691-5826-9371-c4bec6c53f06","name":"Women's health","slug":"womens-health"}],"chapters":[{"id":"e95d24eb-aeb8-50bb-ac51-8f64aea3c30a","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"8ce4dbd7-2246-5775-ae6e-04329c1190c1","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"982a2f05-e887-58b7-b162-572ce0d3ee9f","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"38dfa294-fe36-5eaf-801f-f85edcaf9b0c","slug":"changes","fullItemName":"Changes"},{"id":"3ad7e907-7bc6-5339-9fe3-a53a943a1d5b","slug":"update","fullItemName":"Update"}]},{"id":"cfeab3a1-33f8-5401-bf2d-554006509e44","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"f358fbd3-3112-597d-8318-782024ffb462","slug":"goals","fullItemName":"Goals"},{"id":"06d9f87d-ffb9-5c80-94cc-c14fabec72e4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"00abbaa1-76de-5699-92e4-c7966d120fb9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8c5bcf9e-40a1-5ec5-bfb3-8b61c5e05271","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"9e5947c9-06ae-527b-b39d-99249cc183b7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"acce3106-835f-51e5-8d2a-474eb1210f06","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ede3d467-474d-5337-a3a8-69e962cdb78d","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"fed1d461-c450-5ad2-b137-ba2e7b3e25ba","slug":"definition","fullItemName":"Definition"},{"id":"69ac7b79-9272-52fb-b41a-85c62d368278","slug":"causes","fullItemName":"Causes"},{"id":"540240f7-7b5f-5dd8-9778-add2bad7a948","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f32fb44d-4398-544d-8e12-40abce15c8ac","slug":"prognosis","fullItemName":"Prognosis"},{"id":"d3481fe5-fb32-5604-a01e-ef3831740641","slug":"complications","fullItemName":"Complications"}]},{"id":"ea7b6574-3e2d-5558-b3fc-e26e23ee9841","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"cb8a05d1-5735-53f1-9f3d-a8eeeaf04c43","slug":"assessment","fullItemName":"Assessment"},{"id":"d9fb23e4-f170-5e35-baf1-eb5e9eb3ef93","slug":"causes","fullItemName":"Causes"},{"id":"b2f116aa-c92b-555e-bf3d-4d48002ac082","slug":"investigations","fullItemName":"Investigations"}]},{"id":"33ec4dfa-a698-5c63-ba2b-63ff2bd4f94a","slug":"management","fullItemName":"Management","subChapters":[{"id":"39b5f2b6-2faf-5764-932b-10c3cfa35b9c","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"879b4dcf-9fd5-5785-ad0a-f78ce4711c69","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"40a71a96-802a-52ed-936a-8be2564e3966","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids"},{"id":"5a7e3fc5-3dcc-5ae7-b42c-cfd50c0b6427","slug":"hydroxyzine","fullItemName":"Hydroxyzine"}]},{"id":"e8fd8512-18b4-5a87-b393-c17a7aeea18c","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"22929cbe-97bb-51fd-848d-fb564e84e824","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"16e021f3-7a43-5db6-91c6-f2928df8f0d3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"1e67be49-3ad9-5c49-afd7-3b4003a9e1ac","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"aa214653-3cef-5171-bc52-2abc1dca4efe","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9f82fff6-ebda-5cfb-8995-424680c23073","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3a44b88d-e6de-5027-a2a5-aab8d22fae10","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2255e17a-9ac2-5004-9c32-22c36192790a","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"ab775596-ee36-566c-b99e-f26281476587"}},"staticQueryHashes":["3666801979"]}